Combined Molybdoflavoprotein Enzyme Deficiency

Overview of Combined Molybdoflavoprotein Enzyme Deficiency

Most recent studies have shown that Combined Molybdoflavoprotein Enzyme Deficiency shares some biological mechanisms with atrophy, brain-diseases-metabolic-inborn, cerebral-atrophy, convulsion-neonatal, deficiency-of-xanthine-oxidase, developmental-delay-(disorder), dislocations, encephalomalacia, encephalopathies, epilepsy, hereditary-xanthinuria, inborn-errors-of-metabolism, lens-dislocation, metabolic-diseases, nervous-system-disorder, sulfocysteinuria, trauma-nervous-system.

Among the many pathways, these few ones have gauged particular interests from scientists studying Combined Molybdoflavoprotein Enzyme Deficiency, and have been seen in publications frequently: Cell Death, Excretion, Glycine Receptor Clustering, Glycosylation, Localization, Myelination, Pathogenesis, Proteolysis, Receptor Clustering, Translation, Translation Reinitiation, Transport, Urea Cycle

Quite a number of genes have been found to play important roles in Combined Molybdoflavoprotein Enzyme Deficiency, such as AOX1, CSF2, DPYD, GLRA1, GPHN, LAMC2, MOCS1, MOCS2, MOCS3, PDXP, PLP1, PNP, PRDX5, PTHLH, SUOX, TPI1, TTR, XDH. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Combined Molybdoflavoprotein Enzyme Deficiency Related Genes

click to see detail information for each gene

Pathways Related to Combined Molybdoflavoprotein Enzyme Deficiency

This information is being compiled and will come in a future update

Related Diseases